RLS

Neupro® - rotigotine a dopamine agonist in plaster form was approved 2012-04-03 by FDA - Federal Drug Administration - for use in the treatment of RLS in USA. Neupro® is approved in EU since 2009.

Norway has as country number ten submitted the filled out questionnaires for the patient study EARLS 2010.